[go: up one dir, main page]

NO992009D0 - Nye trans-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer - Google Patents

Nye trans-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer

Info

Publication number
NO992009D0
NO992009D0 NO992009A NO992009A NO992009D0 NO 992009 D0 NO992009 D0 NO 992009D0 NO 992009 A NO992009 A NO 992009A NO 992009 A NO992009 A NO 992009A NO 992009 D0 NO992009 D0 NO 992009D0
Authority
NO
Norway
Prior art keywords
syndromes
estrogen
prevention
treatment
related diseases
Prior art date
Application number
NO992009A
Other languages
English (en)
Other versions
NO992009L (no
Inventor
Poul Jacobsen
Svend Treppendahl
Paul Stanley Bury
Anders Kanstrup
Lise Brown Christiansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO992009D0 publication Critical patent/NO992009D0/no
Publication of NO992009L publication Critical patent/NO992009L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
NO992009A 1996-10-28 1999-04-27 Nye trans-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer NO992009L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK120196 1996-10-28
PCT/DK1997/000481 WO1998018774A1 (en) 1996-10-28 1997-10-28 Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

Publications (2)

Publication Number Publication Date
NO992009D0 true NO992009D0 (no) 1999-04-27
NO992009L NO992009L (no) 1999-06-25

Family

ID=8102120

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992009A NO992009L (no) 1996-10-28 1999-04-27 Nye trans-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer

Country Status (8)

Country Link
EP (1) EP0937059A1 (no)
JP (1) JP2001502706A (no)
AU (1) AU744403B2 (no)
CA (1) CA2269936A1 (no)
IL (1) IL129623A0 (no)
NO (1) NO992009L (no)
WO (1) WO1998018774A1 (no)
ZA (1) ZA979643B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2185054T3 (es) * 1996-12-13 2003-04-16 Chugai Pharmaceutical Co Ltd Derivados de benzopirano.
JP2002533456A (ja) * 1998-12-30 2002-10-08 シグナル ファーマシューティカルズ， インコーポレイテッド エストロゲン受容体のモジュレートを行うための化合物および方法
PT1355906E (pt) * 2001-01-24 2005-05-31 Chiesi Farma Spa Derivados de 2h-1-benzopirano processos para a sua preparacao e as suas composicoes farmaceuticas
JP4976649B2 (ja) * 2004-09-21 2012-07-18 マーシャル エドワーズ，インク． 化合物
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
NZ553834A (en) 2004-09-21 2010-03-26 Novogen Res Pty Ltd 7-hydroxy-3,4-diphenyl-chroman and chromene derivatives
ES2773732T3 (es) 2010-11-01 2020-07-14 Mei Pharma Inc Composiciones de isoflavonoides y procedimientos para el tratamiento del cáncer
HUE054998T2 (hu) 2015-02-02 2021-10-28 Mei Pharma Inc Kombinációs terápiák emlõrák kezelésében való alkalmazásra

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340276A (en) * 1964-04-01 1967-09-05 Ciba Geigy Corp 3, 4-diphenyl-chromans
DE1543749A1 (de) * 1966-02-16 1969-12-11 Merck Ag E Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
HUP9702244A3 (en) * 1995-01-13 1999-12-28 Novo Nordisk As Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders

Also Published As

Publication number Publication date
AU4771897A (en) 1998-05-22
EP0937059A1 (en) 1999-08-25
CA2269936A1 (en) 1998-05-07
WO1998018774A1 (en) 1998-05-07
NO992009L (no) 1999-06-25
ZA979643B (en) 1998-04-28
IL129623A0 (en) 2000-02-29
AU744403B2 (en) 2002-02-21
JP2001502706A (ja) 2001-02-27

Similar Documents

Publication Publication Date Title
ID18925A (id) Penggunaan benzazol-benzazol yang disubstitusi sebagai absorben-absorben uv, benzazol-benzazol baru dan proses-proses untuk pembuatannya
NO944857D0 (no) Fluorenyl-inneholdende metallocener, fremgangsmåte for fremstilling derav og fremgangsmåte for polymerisering av olefiner ved anvendelse av metallocenene
FI942452A7 (fi) Formuloinnit, jotka sisältävät karotenoideja ja prokarotenoideja, jotka on yhdistetty polyfenoleihin vammojen ehkäisyssä, jotka johtuvat epänormaalista vapaaradikaalituotannosta
EE03338B1 (et) Tromboosivastane ravim, selle valmistamise protsess ja kasutamine
FI971783L (fi) Adenoviruksia, joissa ei ole elinkykyisiä kontaminoivia partikkeleita, niiden valmistus ja käyttöjä
FI921260A0 (fi) Faestanordning foer loeslagbar anslutning av tvao profilstycken.
EE9700044A (et) Heteroarüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid.
TR199500952A2 (tr) Anti-astimatik, anti-alerjik, anti-enflamatuar ve imünmodüle edici etkiye sahip yeni n-benzilindol ve benzopirazol türevleri.
DK0760238T3 (da) Præparat, der kan indgives perkutant, til behandling af vandladningslidelse
NO990701D0 (no) Behandling av vanlig forkj°lelse eller allergisk rhinitt
NO864241L (no) Fremgangsmaate ved bleking av cellulosemasse eller fraksjon derav, anlegg til bruk ved gjennomfoeringen av fremgangsmaaten og skruepresse, saerlig til bruk ved fremgangsmaaten henholdsvis i anlegget.
DK0630600T3 (da) Seng eller soveplads, som kan trækkes ind i loftet
NO911956L (no) Fremgangsmaate for fremstilling av oxydant sensitive og insensitive, aromatiske estere som inhibitorer for human neutrofil elastase
NO20015605D0 (no) Substituerte polysykliske aryl- og heteroarylpyrazinoner som er anvendbare for selektiv inhibering av koagulasjonskaskaden
NO992009D0 (no) Nye trans-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer
NO992010D0 (no) Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer
NO20015772L (no) Forbindelser og fremgangsmåter for behandling av post- traumatisk stress-syndrom
NO992005D0 (no) Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer
NO992008D0 (no) Nye (+)-enantiomerer av cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer
NO953989D0 (no) Nye polysykliske systemer og derivater derav, som neurotransmitter frigivelses-forsökende midler som er anvendbare ved behandling av kognitive sykdommer
NO20005698L (no) Nye 1,2,5-trisubstituerte 1,2-dihydro-indazol-3-oner med antiastmatisk, antiallergisk, betennelseshemmende, immunomodulerende og neuroprotektiv virkning, fremgangsmåter for deres fremstilling og deres anvendelse som legemiddel
NO984760D0 (no) Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon
NO992002D0 (no) Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer
NO992004D0 (no) Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer
NO905012D0 (no) Fremgangsmaate til fremstilling av cefemer, oksacefemer ogkarbacefemer og 3-sulfonyloksy-substituerte cefemer, oksacefemer og karbacefemer som utgangsprodukt ved fremgangsmaaten.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application